Skip to content
Back to Guavy Wire
Stocks

Finasteride Market Sees Steady Growth Through 2033, Reaching $194.5 Mn

Instruments
MRK
Share

The global finasteride market is expected to experience steady growth over the next seven years. According to recent research, the market will reach USD 194.5 Mn by 2033, up from USD 150.0 Mn in 2026, registering a compound annual growth rate (CAGR) of 3.8% during this period.

The market is driven by the increasing demand for finasteride, a medication used to treat benign prostatic hyperplasia (BPH) and male pattern baldness. The report highlights key trends, including emerging opportunities in the dermatology and urology clinics sectors.

Market leaders, such as Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., and Sandoz Group AG, are expected to maintain their market share due to their strong product portfolios and strategic business initiatives.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc